Table:
begin	end	state
1	24	cytoplasmic
25	49	transmembrane
50	59	non-cytoplasmic
60	84	transmembrane
85	95	cytoplasmic
96	114	transmembrane
115	119	non-cytoplasmic
120	145	transmembrane
146	162	cytoplasmic
163	188	transmembrane
189	195	non-cytoplasmic
196	217	transmembrane
218	249	cytoplasmic
250	273	transmembrane
274	284	non-cytoplasmic
285	304	transmembrane
305	315	cytoplasmic
316	334	transmembrane
335	340	non-cytoplasmic
341	368	transmembrane
369	380	cytoplasmic
381	404	transmembrane
405	409	non-cytoplasmic
410	428	transmembrane
429	459	cytoplasmic

Input:
>Pf1N1B4_180 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_180
MSDLSPVEKSGAPPEVAISMKKVAVASVIGTTVEWYDLFVFATASALVFNKVFFPDFDPL
IGTLLAFGTFASAYLARIVGAALFGHFGDRLGRKSMLLVSLLTMGAATFAIGLLPNYAAI
GIWAPILLLLLRVIQGLALGGEWGGAVLMAVEHAPANKRGLYGSWVQIGVPAGTMIANLA
FLVIAAWLSPEDLLAWGWRIPFLASVLLIAVGLYIRLNISETPAFNKVKEAEVQVKMPLA
EVFRKYWKQVVLGGIATMSTGASFNIIVAFGLTYGTQNLGFSRSVMLGVVLLSCAWCIVM
LPVFGALSDRYGRKPIIVAGIVAEALVAFPMFWLMDTKELSLVIFGYLLLMTAFAANYGP
IATFLAELFGTRVRYSGLSISYMLSGLLGSAATPIVTTALLAATGKGSSVAWYMIGAAFI
SLVALLLLTETFKRDISEIQTAVPAADPALGKPIKSAAA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server